GE HealthCare said on March 13, 2026 that its Board appointed Kevin A. Lobo as a director with immediate effect. His term expires at the 2026 Annual Meeting of Stockholders. The Board also named him to the Talent, Culture, and Compensation Committee.

1. 01

   GE HealthCare said on March 13, 2026 that its Board appointed Kevin A. Lobo as a director with immediate effect. His term expires at the 2026 Annual Meeting of Stockholders. The Board also named him to the Talent, Culture, and Compensation Committee.

2. 02

   The company said Mr. Lobo will receive compensation under its non-employee director compensation program and will enter into an indemnification agreement with him. It also said there is no arrangement or understanding tied to his selection, and no transactions with him that are reportable under Item 404(a).

3. 03

   The company said Risa Lavizzo-Mourey and Tomislav Mihaljevic told the Board on March 13, 2026 that they will not stand for re-election at the 2026 Annual Meeting of Stockholders due to other commitments. It said their decisions did not result from any disagreement over the company's operations, policies or practices.

4. 04

   In a press release, the company described Lobo as Chair and Chief Executive Officer of Stryker Corporation with more than 25 years of experience in medical technology, operations and finance. The company said he has been Stryker's CEO since October 2012 and its board chair since July 2014.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.